Death receptor-mediated suicide: a novel target of autoimmune disease treatment

Abstract

In the thymus, based on the reactivity of their T-cell receptor with self-MHC and antigenic peptides, developing immature T-cells undergo positive and negative selection. Cells recognising self-peptides and MHC with high affinity are considered autoreactive, and thus potentially harmful, and are eliminated by induction of apoptotic cell death. Thymic negative selection is, however, only incomplete and autoreactive T-cells escape into the periphery. It is not the presence of autoreactive mature T- and B-lymphocytes as the underlying cause of tissue destruction and development of autoimmune diseases, but their uncontrolled and excessive clonal expansion upon activation by self-antigen. Thus, potent regulatory mechanisms must keep these autoreactive cells under control to avoid their inappropriate activation. Recent evidence indicates that death receptors of the tumour necrosis factor receptor family play a central role in mediating antigen receptor-induced suicide of autoreactive T-lymphocytes. Defects in these apoptosis-inducing regulatory mechanisms may result in the development of autoimmune diseases. Therefore, enhancing the cell's own suicide program, offers a most attractive therapeutic target for the treatment of autoimmune diseases.

Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence

“…Most autoimmune diseases appear to be mediated by CD4 + T cells; however, CD8 + T cells are also involved in excessive and destructive immunopathologies, such as acute graft-versus-host disease, hepatitis, or graft rejection, and may also be involved in the exacerbation of autoimmune disorders, such as type I diabetes or inflammatory bowel disease (34)(35)(36). Thus, enhancing the cells' own suicide program offers an attractive target for the treatment of such diseases (13,37,38). …”